Table 1.
Demographics and Clinical Measures by Change in Suicidal Severity.
| All | Decreased IDS‐SR item #18 | Increased IDS‐SR item #18 | No change IDS‐SR item #18 | |
|---|---|---|---|---|
| n | 25 | 11 | 3 | 11 |
| Age, mean (SD) | 52.4 (10.0) | 59.2 (6) | 47.0 (19.6) | 46.7 (10.0) |
| Females, n (%) | 12 (48) | 5 (45) | 2 (67) | 5 (45) |
| IDS‐SR | ||||
| Baseline, mean (SD) | 45.4 (12.4) | 45.9 (16.6) | 46.9 (15.9) | 43.6 (9.7) |
| End point, mean (SD) | 27.2 (17.9) | 20.6 (18.7) | 31.9 (15.5) | 30.0 (18.3) |
| % change, mean (SD) | 42.6 (31.3) | 58.8 (21.5) | 27.8 (33.3) | 33.2 (35.5) |
| PCL | ||||
| Baseline, mean (SD) | 49 (12.6) | 47.2 (13.2) | 47.6 (17.5) | 48.6 (12.9) |
| End point, mean (SD) | 28.5 (19.0) | 20.9 (20.0) | 31.1 (15.1) | 32.5 (19.2) |
| % change, mean (SD) | 41.8 (38.0) | 58.0 (33.4) | 29.3 (37.1) | 30.2 (42.2) |
| Medications* | ||||
| Antidepressants, n (%) | 18 (72) | 6 (55) | 2 (67) | 10 (91) |
| Benzodiazepines, n (%) | 10 (40) | 5 (45) | 1 (33) | 4 (36) |
| Anticonvulsants, n (%) | 5 (20) | 3 (27) | 0 (0) | 2 (18) |
| Antipsychotics, n (%) | 10 (40) | 5 (45) | 0 (0) | 5 (45) |
| Stimulants, n (%) | 7 (28) | 3 (27) | 1 (33) | 3 (27) |
Descriptive data for participants grouped according to change in IDS‐SR item #18 score following a course of 5 Hz TMS treatment for comorbid PTSD and depression.
*Note that medications were stable for at least six weeks prior to stimulation.